TrialBritish journal of clinical pharmacology2013

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects.

Charles Frost et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.